肠道菌群
医学
失调
药品
肝损伤
抗生素
免疫系统
免疫学
发病机制
药物代谢
氧化应激
药理学
微生物学
生物
内科学
作者
Huikuan Chu,Yan Ai,Zilu Cheng,Ling Yang,Xiaohua Hou
标识
DOI:10.1016/j.hbpd.2023.06.008
摘要
Drug-induced liver injury (DILI) is caused by various drugs with complex pathogenesis, and diverse clinical and pathological phenotypes. Drugs damage the liver directly through drug hepatotoxicity, or indirectly through drug-mediated oxidative stress, immune injury and inflammatory insult, which eventually lead to hepatocyte necrosis. Recent studies have found that the composition, relative content and distribution of gut microbiota in patients and animal models of DILI have changed significantly. It has been confirmed that gut microbial dysbiosis brings about intestinal barrier destruction and microorganisms translocation, and the alteration of microbial metabolites may cause or aggravate DILI. In addition, antibiotics, probiotics, and fecal microbiota transplantation are all emerging as prospective therapeutic methods for DILI by regulating the gut microbiota. In this review, we discussed how the altered gut microbiota participates in DILI.
科研通智能强力驱动
Strongly Powered by AbleSci AI